|
|
|
|
|
|
|
Haemonetics Corporation (HAE)
|
|
104.9 1.02 (0.98%)
|
08-21 16:02
|
|
Open:
|
103.88
|
Pre. Close:
|
103.88
|
|
High:
|
105.32
|
Low:
|
103.67
|
|
Volume:
|
446,525
|
Market Cap:
|
5422M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
105.446 - 105.852
|
105.852 - 106.257
|
|
Low:
|
102.592 - 103.084
|
103.084 - 103.577
|
|
Close:
|
104.11 - 104.86
|
104.86 - 105.61
|
|
|
|
Technical analysis (as of: 2018-08-21 4:25:53 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 126.58 One year: 147.84
|
|
Support:
|
Support1: 100.11  Support2: 95.01
|
|
Resistance:
|
Resistance1:
108.37 Resistance2: 126.58
|
|
Pivot:
|
101.16
|
|
Moving Averages:
|
MA(5): 103.80 MA(20): 100.50
MA(100): 89.33 MA(250): 70.18
|
|
MACD:
|
MACD(12,26):
2.28 Signal(12,26,9): 2.04
|
|
%K %D:
|
%K(14,3): 68.01 %D(3): 64.97
|
|
RSI:
|
RSI(14): 65.91
|
|
52-Week:
|
High: 108.37
Low: 41.1 Change(%): 153.9
|
|
Average Vol(K):
|
3-Month: 80189
10-Days 43826
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.HAE has closed below upper band by 18.7%. Bollinger Bands are 43.4% wider than normal. The large width of the bands suggest high volatility as compared to HAE's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
2018-08-07T11:30:52-04:00
Haemonetics Corp's (HAE) CEO Christopher Simon on Q1 2019 Results - Earnings Call Transcript
2018-08-07T06:30:00-04:00
Haemonetics Appoints Josep Lluis Llorens As Senior Vice President, Global Manufacturing And Supply Chain
2018-08-07T06:02:15-04:00
Haemonetics beats by $0.17, beats on revenue
2018-08-07T06:00:00-04:00
Haemonetics 1st Quarter Fiscal 2019 Earnings Release Available on Investor Relations Website
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
